The Florida Melanoma Trial I: A Prospective Multicenter Phase I/II Trial of Postoperative Hypofractionated Adjuvant Radiotherapy with Concurrent Interferon-Alfa-2b in the Treatment of Advanced Stage III Melanoma with Long-Term Toxicity Follow-Up
Figure 2
Kaplan-Meier curve and pointwise confidence intervals for overall survival (): 13 (57%) deaths; median OS = 34.5 months.